Fertility treatment is an expensive, emotionally charged, often self-funded decision, and patients research it exhaustively. It is also one of the few medical categories where outcome data is collected and published nationally, which makes success rate claims both checkable and easy to present misleadingly.
Success rates are reported and comparable
Clinic outcome data is reported under federal requirements and published, which means a prospective patient can compare. Advertising a rate without the population, age band, cycle type and measure it refers to is the classic misuse, and it is checkable against the published data, so a clinic doing it will eventually be caught out by a well informed patient.
Tone is a commercial decision here
Patients arrive after months or years of difficulty. Marketing that is breezy, that leads with imagery of babies, or that implies outcomes are a matter of choosing the right clinic lands badly on people who have already had disappointments. The clinics that convert tend to be the ones that acknowledge the difficulty honestly.
Cost transparency is a genuine differentiator
Treatment is largely self-funded and pricing is famously opaque, with add-ons, medication and storage often excluded from headline figures. Publishing what a cycle includes and what it does not is rare and is exactly what patients research, which makes it one of the highest returning pages a clinic can publish.
Privacy is acute in this category
Patient stories are powerful and require valid authorisation for marketing use, and the sensitivity here is higher than in most specialties. Reviews should be answered with a general reply inviting private contact, since acknowledging a specific patient's treatment is a disclosure regardless of intent.
Questions people ask about fertility clinic marketing
Can a clinic advertise its success rate?
With the population, age band, cycle type and measure clearly stated. Rates are reported nationally and a figure presented without its context is both misleading and checkable.
Should prices be published?
It is a strong differentiator in a category known for opacity, particularly where add-ons and medication are listed separately rather than hidden.
How should patient stories be handled?
With valid written authorisation for marketing use, sensitively, and with recognition that not every prospective patient wants to read a success story.